Pulmagen Therapeutics (Synergy) Limited;AstraZeneca AB
发明人:
Ford, Rhonan Lee,Mather, Andrew Nigel,Bull, Richard James,Skidmore, Elizabeth Anne,Mete, Antonio
申请号：
AU2008356409
公开号：
AU2008356409B2
申请日:
2008.05.13
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention provides named compounds of formula (I ), wherein R4 is a N- sustituted quinuclidine ( I ) pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions. Their use in therapy for' the treatment of conditions mediated by M3 muscarinic receptors, such as chronic obstructive pulmonary disease is also disclosed.
